DDInter1084 DDInter1016
Lomefloxacin is a fluoroquinolone antibiotic, used to treat bacterial infections including bronchitis and urinary tract infections (UTIs). Additionally, it has been employed for the prophylaxis of UTIs prior to surgery as well.
Lactitol, also known as 4-β-D-galactopyranosyl-D-glucitol, is a sugar alcohol synthesized from [lactose]. It is used in food manufacturing as a nutritive sweetener and is approximately 35% as sweet as table sugar (i.e. [sucrose]). Clinically, lactitol has been investigated for use as an osmotic laxative and, along with other non-absorbable disaccharides such as [lactulose], in the treatment of hepatic encephalopathy in patients with cirrhosis.[A190915,A190918] Pizensy, an oral lactitol powder for solution, was approved by the FDA for use in chronic idiopathic constipation in February 2020.
Lomefloxacin {u} (Compound) resembles {v} (Compound) Sparfloxacin
Lomefloxacin {u} (Compound) resembles {v} (Compound) Moxifloxacin
Lomefloxacin {u} (Compound) binds {v} (Gene) TOP2A
Lomefloxacin {u} (Compound) causes {v} (Side Effect) Potassium low
Lomefloxacin {u} may cause a minor interaction that can limit clinical effects when taken with {v} Daunorubicin
Lomefloxacin {u} may cause a minor interaction that can limit clinical effects when taken with {v} Cytarabine
Lomefloxacin {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Bisacodyl
Lomefloxacin {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Methoxsalen
Lomefloxacin {u} may lead to a major life threatening interaction when taken with {v} Methylprednisolone
Lomefloxacin {u} may lead to a major life threatening interaction when taken with {v} Ivosidenib
Lomefloxacin (Compound) resembles Sparfloxacin (Compound)
Lomefloxacin (Compound) resembles Moxifloxacin (Compound)
Lomefloxacin (Compound) binds TOP2A (Gene)
Lomefloxacin (Compound) causes Potassium low (Side Effect)
Lomefloxacin may cause a minor interaction that can limit clinical effects when taken with Daunorubicin
Lomefloxacin may cause a minor interaction that can limit clinical effects when taken with Cytarabine
Lomefloxacin may cause a moderate interaction that could exacerbate diseases when taken with Bisacodyl
Lomefloxacin may cause a moderate interaction that could exacerbate diseases when taken with Methoxsalen
Lomefloxacin may lead to a major life threatening interaction when taken with Methylprednisolone
Lomefloxacin may lead to a major life threatening interaction when taken with Ivosidenib